FendX Technologies
Menu
FendX Technologies, Inc. is platform technology company that develops pathogen-repelling surface coatings to prevent the spread of pathogens. It focuses on the development and commercialization of surface protection coating technology. The company was founded on July 28, 2020 and is headquartered in Oakville, Canada.
Don't miss out! Sign up below to learn more about this investment opportunity.
FendX Technologies (FDXTF) On
- FendX’s Nanotechnology to be Presented at the Infection Prevention and Control Canada National Conference
- FendX Announces Fourth Real-World Testing Site for REPELWRAP(TM) Film with Draganfly Inc.
- FendX’s Nanotechnology to Be Presented at the Canadian Chemistry Conference and Exhibition, CSC 2024
- FendX Announces New Development Opportunity of Its Spray Nano-Coating That Uses AI and Sensors to Detect Contamination on Surfaces
- FendX Technologies Announces Closing of Non-Brokered Private Placement with Strategic Investors and Upsizing
9 Reasons To Make A Move Into FendX Technologies (FDXTF)
- DISRUPTER – FendX Technologies (FDXTF) is developing something new to the antimicrobial wrap marketplace. Its competitors try to kill pathogens, while FendX’s REPELWRAP™ film aims to keep surfaces clean and deadly pathogens at bay.
- HEADLINE MAKER – REPELWRAP™ film is big news. Throughout this report you’ve seen the big-time headlines it’s made in outlets such as CNN, USA Today, and The Independent.
- REAL WORLD TESTING – REPELWRAP™ film is poised to enter into real world testing to confirm its ability to repel pathogens at Island View Place Care in British Columbia. Island Care is a high-quality care facility tailored for seniors and those requiring memory care. For me, this is a perfect place to test because senior citizens are vulnerable to pathogen attacks. It will also be tested at other venues including a restaurant and entertainment venues.[47]
- THE NEXT MCMASTER IP LICENSEE WINNER – FendX Technologies is one of 26 companies that has licensed intellectual property from McMaster University’s. Like FendX, a number are publicly traded. And, Fusion Pharmaceuticals was just acquired by Astra Zeneca for $2.4 billion. McMasters breeds success.[48][49]
- TOP MANAGEMENT I -- CEO, Dr. Carolyn Myers is an accomplished senior executive with extensive experience leading healthcare businesses. She is also a Principal of BioEnsemble LLC, where she works closely with numerous start-ups and small pharma companies to assist them in developing their business strategy and planning. Her previous executive positions include those as President of Dey Laboratories, President of Mylan Technologies, as well a management at Pharmacia Corp., now a part of Pfizer.[50]
- TOP MANAGEMENT II –COO, Andrea Mulder is an accomplished senior commercial healthcare executive with extensive experience launch pharmaceutical and biotechnology corporations. She has significant therapeutic knowledge across multiple areas including infectious disease, immunology, neurology, respiratory and oncology. She’s led global leadership teams at SmithKline, Roche, Johnson and Johnson and Pfizer.
- STUNNING OPPORTUNITY – The industry forecast says the global antimicrobial coatings market could have as much as $20.7 billion up for grabs by 2028 – less than four years away.[51]*
- WILD CARD – It is rare to find me speculating about a buyout or merger. But, FendX Technologies (FDXTF) and its REPELWRAP™ film, have the potential to disrupt the antimicrobial wrap market.
- $$$ REALITY – FendX Technologies (FDXTF) is a penny stock, but people are discovering it… shares are up 108% for the year, as I write, on volume that’s under 50,000 shares a day.[52]
Don't miss out! Sign up below to learn more about this investment opportunity.
When you sign up, you'll also receive the InvestingTrends newsletter...absolutely free! Get actionable investment ideas and market commentary delivered right to your inbox five times a week. And of course, you can unsubscribe at any time, view our Privacy Policy here.
Don't miss out! Sign up below to learn more about this investment opportunity.
When you sign up, you'll also receive the InvestingTrends newsletter...absolutely free! Get actionable investment ideas and market commentary delivered right to your inbox five times a week. And of course, you can unsubscribe at any time, view our Privacy Policy here.
ADVERTISEMENT DISCLAIMER
This PUBLICATION is an issuer-paid advertisement. This paid advertisement includes a stock profile of FendX Technologies (FDXTF). To enhance public awareness of FDXTF and its securities, the issuer has provided i2i Marketing Group, LLC (“i2i”) with a total budget of approximately two hundred fifty thousand ($250,000.00) USD to cover the costs associated with this advertisement for a period beginning 10 June 2024 and currently set to end 15 July 2024. In connection with this effort, i2i has paid the author of this advertisement, James Hyerczyk, two thousand five hundred ($2,500.00) USD in cash out of the total budget. The website hosting this advertisement, Investing Trends, is owned by i2i. As a result of this advertisement, Investing Trends may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. I2i will retain any excess sums after all expenses are paid. James Hyerczyk is solely responsible for the contents of this advertisement. As of the date this advertisement is posted to the Investing Trends website, some or all of i2i, Investing Trends, or James Hyerczyk, and any of their respective officers, principals, or affiliates (as defined in the Securities Act of 1933, as amended, and Rule 501(b) promulgated there under) may hold the securities of FDXTF’s and may sell those shares during the course of this advertising campaign. This advertisement may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of FDXTF’s, increased trading volume, and possibly an increased share price of FDXTF’s securities, which may or may not be temporary and decrease once the advertising campaign has ended.
To more fully understand the Investing Trends website or service, please review its full Disclaimer and Disclosure Policy.
To more fully understand the Investing Trends website or service, please review its full Disclaimer and Disclosure Policy.
[47] https://www.newsfilecorp.com/release/208842/FendX-Announces-Second-RealWorld-Testing-Site-for-REPELWRAPTM-Film-with-Island-View-Place-Care-and-Provides-Corporate-Update
[48] https://brighterworld.mcmaster.ca/articles/astrazeneca-to-acquire-mcmaster-supported-fusion-pharmaceuticals/
[49] https://research.mcmaster.ca/industry-investors/support-our-startups/startups-list/
[50] https://fendxtech.com/about-us/leadership-team-directors/
[51] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835042/#B12-ijms-23-01162
[52] https://finance.yahoo.com/quote/FDXTF/history
© 2024 Investing Trends. All Rights Reserved.
